Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Resistant Starch Type 3 (RS3) is retrograded amylose formed when cooked starches cool, resisting digestion in the small intestine. It then ferments in the colon, producing beneficial short-chain fatty acids like butyrate that support gut health.
Reported Benefits (Provisional)
Origin & History
Resistant Starch Type 3 (RS3) is a retrograded starch formed when starchy foods like potatoes, rice, or legumes are cooked and then cooled. Unlike typical starches, RS3 is not digested in the small intestine, allowing it to reach the colon where it acts as a potent prebiotic. It feeds beneficial gut bacteria, supporting digestive and metabolic health, and is widely used in functional foods and supplements.
Research Narrative (Provisional)
Numerous studies confirm the prebiotic benefits of RS3, particularly its role in promoting gut health, enhancing blood sugar regulation, and supporting colon health. Research also highlights its ability to support weight management and reduce inflammation through the production of SCFAs like butyrate.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Prebiotics: Nourish beneficial gut bacteria and improve microbiome diversity. - Short-Chain Fatty Acids (SCFAs): Produced by gut bacteria, supporting colon health and reducing inflammation. - Low Glycemic Index: Contributes to stable blood sugar levels. - Fiber: Supports digestive regularity and promotes satiety. - Resistant Properties: Remains undigested in the small intestine, delivering benefits directly to the colon.
Reported Mechanism (Provisional)
Resistant Starch Type 3 (RS3) consists primarily of retrograded amylose, formed into tightly packed, thermostable double helices during the cooling of cooked starchy foods. This crystalline structure prevents enzymatic hydrolysis by amylase in the small intestine, allowing RS3 to reach the colon intact. There, it is fermented by specific gut microbiota into short-chain fatty acids (SCFAs) such as butyrate, propionate, and acetate, which nourish colon cells, modulate gut pH, and exert systemic metabolic benefits.
Clinical Narrative (Provisional)
Numerous clinical and mechanistic studies confirm the significant health benefits of Resistant Starch Type 3. Research highlights its potent prebiotic effects, showing increased populations of beneficial gut bacteria like Bifidobacteria and Lactobacilli. Studies also demonstrate improved insulin sensitivity, better blood sugar regulation, and enhanced satiety, contributing to weight management. Furthermore, the production of SCFAs like butyrate is linked to reduced systemic inflammation and improved colon health.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.